Ligand Pharmaceuticals Inc (LGND) News Headlines

▮ More

Date

Headline

12/2/2019 8:33:41 AM Ligand Enters Worldwide OmniAb License Agreement With Sanofi

11/8/2019 8:34:50 AM Ligand Pharma Unveils Positive Results From Phase 1 Trial of Captisol-enabled Iohexol Program At ASN Kidney Week 2019

11/5/2019 4:44:15 PM Ligand Pharma Updates Earnings Guidance - Quick Facts

11/5/2019 4:11:45 PM Ligand Pharmaceuticals Inc Q3 adjusted earnings Miss Estimates

11/5/2019 4:09:34 PM Ligand Pharmaceuticals Inc (LGND) Has Lowered Its 2019 EPS Estimate To 3.00 From 3.20

11/5/2019 4:05:24 PM Ligand Pharmaceuticals Q3 Loss Per Share $0.81 Vs EPS $2.80 Prior Year

11/5/2019 3:02:35 PM Ligand Pharmaceuticals Q3 19 Earnings Conference Call At 4:30 PM ET

10/15/2019 9:05:33 AM Ligand Appoints Sarah Boyce To Board

7/31/2019 1:25:21 AM 5 Top Losers In Healthcare Sector (RMTI, LGND, MIST...)

7/30/2019 8:11:33 AM Ligand Pharmaceuticals Inc Q2 adjusted earnings Beat Estimates

7/30/2019 8:04:00 AM Ligand Pharma Q2 Loss Per Share $0.74 Vs Profit $2.99 Last Year

7/30/2019 8:00:16 AM Ligand Pharmaceuticals Q2 19 Earnings Conference Call At 9:00 AM ET

7/23/2019 4:35:39 PM Ligand Pharmaceuticals Acquires Ab Initio Biotherapeutics

7/10/2019 9:05:07 AM Ligand Report Positive Top Line Results From Phase 1 Trial Of CE Iohexol Program

7/8/2019 8:32:14 AM Ligand And SQ Innovation Enter Into Exclusive Worldwide Captisol License And Supply Deals For Furosemide Formulation

3/21/2019 9:10:04 AM Ligand To Receive $3 Mln Milestone Payment As Result Of FDA Approval Of Sage Therapeutics’ ZULRESSOTM Injection

2/7/2019 5:14:03 PM Ligand Pharma Q4 Loss/share $2.02 Vs. Loss $0.33 Year Ago

2/7/2019 9:00:35 AM Ligand Pharmaceuticals Enters Worldwide OmniAb Partnership With Genagon Therapeutics AB

2/4/2019 4:12:23 PM Ligand Announces Closing Investment In Dianomi Therapeutics

1/25/2019 9:02:35 AM Ligand Partner Seelos Therapeutics Becomes Public Company